Snowden Capital Advisors »

Immix Biopharma shares owned by Snowden Capital Advisors

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Snowden Capital Advisors from 13F filings

Historical chart of Snowden Capital Advisors investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Snowden Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Snowden Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $52k 10k 5.23
2025-09-30 $21k 10k 2.09

More positions owned by Snowden Capital Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Spdr Series Trust State Street Spd (SPYM)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
JPMorgan Chase & Co. (JPM)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Meta Platforms Cl A (META)
Palantir Technologies Cl A (PLTR)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Snowden Capital Advisors

Top funds holding Immix Biopharma

Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Group
Logos Global Management
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
Ameriprise Financial
Burkehill Global Management
Renaissance Technologies
Geode Capital Management
KVP Capital Advisors
Goldman Sachs Group

View all funds holding Immix Biopharma